US2012035148A1PendingUtilityA1

Ophthalmic compositions and methods for treating ophthalmic conditions

56
Assignee: WHITCUP SCOTT MPriority: Jul 12, 2004Filed: Sep 19, 2011Published: Feb 9, 2012
Est. expiryJul 12, 2024(expired)· nominal 20-yr term from priority
A61P 33/02A61P 35/00A61P 31/12A61K 45/06A61K 31/573A61K 31/44A61K 31/57A61P 27/02A61P 29/00A61K 31/56A61K 9/0048A61K 9/0051A61K 47/34A61K 31/575A61K 31/58A61K 47/38A61K 9/0024
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Compositions, and methods of using such compositions, useful for placement, for example injection, into the interior of human or animal eyes are provided. Such compositions include a therapeutic component, such as one or more corticosteroids, a biocompatible polymeric component, and a solvent component.

Claims

exact text as granted — not AI-modified
1 .- 32 . (canceled) 
     
     
         33 . A method of treating a condition of the eye, the method comprising placing into the interior of the eye of a human or animal an ophthalmic composition in fluid form, the composition comprising: a corticosteroid component present in a therapeutically effective amount; a biocompatible polymeric component in an amount effective to delay release of the corticosteroid component into the interior of the eye after the composition is intraocularly placed in the eye; and an ophthalmically compatible solvent component in an amount effective to solubilize the polymeric component, the composition adapted to form a delayed release solid, semi-solid or moldable drug-releasing element after contact with fluid in the interior of the eye and effective to delay the release of the corticosteriod component in the eye relative to intraocular placement of a substantially identical composition without the polymeric component wherein said polymeric component is selected from the group consisting of polylactides, polyglycolides, polycaprolactones, polyanhydrides, polyamides, polyurethanes, polyesteramides, polyorthoesters, polydioxanones, polyacetals, polyketals, polycarbonates, polyorthoesters, polyphosphazenes, polyhydroxybutyrates, polyhydroxyvalerates, polyalkylene oxalates, polyalkylene succinates, poly(malic acid), poly(amino acids), poly(methyl vinyl ether), poly(maleic anhydride), polylactic acid, polyglycolic acid, polylactic acid/glycolic acid, chitin, chitosan, copolymers thereof, combinations thereof and mixtures thereof, and wherein the corticosteroid component is selected from the group consisting of triamcinolone acetonide, triamcinolone hexacatonide, and triamcinolone, salts thereof, and mixtures thereof.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.